Psychosocial Screening for Neuroendocrine Tumor Patients

Peking University100 enrolled

Overview

This is a psychosocial screening application to usual care in a cohort of neuroendocrine tumor patients. The application involves monitoring using the NCCN Distress Thermometer(DT), Hospital Anxiety and Depression Scale(HADS), Self-Perceived Burden Scale(SPBS) and Connor-Davidson Resilience Scale(CD-RISC). These assessments will be completed at baseline, 3 months, 6 months, 12 months and 24 months. Patients will have the option of filling out questionnaires more frequently if desired.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Neuroendocrine Tumors

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. sign written informed consent form; 2. age ≥ 18 years; 3. pathologically confirmed well-differentiated neuroendocrine tumors, G1-2 (Ki67≤20%); Exclusion Criteria: 1. \<18 years; 2. Neuroendocrine carcinoma; 3. History of psychiatric or psychologic illness; 4. History of previous cancers or cancer distress; 5. Patients with central nervous system(CNS) disorder； 6. Severe, uncontrolled medical condition that would affect patients' compliance;

Locations (1)

Beijing Cancer Hospital

Beijing, Beijing Municipality, China

RECRUITING

Outcomes

Primary Outcomes

Distress Thermometer

Time frame: every 3 month until 24 month

Secondary Outcomes

HADS

Hospital Anxiety and Depression Scale

Time frame: every 3 month until 24 month

SPBS

Self-Perceived Burden Scale

Time frame: every 3 month until 24 month

CD-RISC

Connor-Davidson Resilience Scale

Time frame: every 3 month until 24 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.